CCEL - CRYO-CELL International, Inc. Stock Price, Fair Value and News

$7.78-0.26 (-3.23%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

CCEL Price Action

Last 7 days

-15.2%

Last 30 days

25.1%

Last 90 days

14.2%

Trailing 12 Months

79.7%

CCEL RSI Chart

CCEL Valuation

Market Cap

62.7M

Price/Earnings (Trailing)

-7.03

Price/Sales (Trailing)

1.97

EV/EBITDA

-5.79

Price/Free Cashflow

20.31

CCEL Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

CCEL Fundamentals

CCEL Revenue

Revenue (TTM)

31.8M

Rev. Growth (Yr)

2.5%

Rev. Growth (Qtr)

0.3%

CCEL Earnings

Earnings (TTM)

-8.9M

Earnings Growth (Yr)

54.53%

Earnings Growth (Qtr)

60.37%

CCEL Profitability

EBT Margin

-38.78%

Return on Equity

93.38%

Return on Assets

-14.18%

Free Cashflow Yield

4.92%

CCEL Investor Care

Dividend Yield

14.54%

Dividend/Share (TTM)

0.9

Buy Backs (1Y)

2.71%

Diluted EPS (TTM)

-1.06

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	31.4M	31.6M	31.8M	0
2023	30.9M	31.0M	31.2M	31.3M
2022	29.3M	29.7M	29.9M	30.3M
2021	30.4M	29.7M	29.1M	28.9M
2020	31.9M	31.7M	31.6M	31.1M
2019	30.5M	32.1M	32.4M	31.8M
2018	25.8M	26.1M	27.1M	29.2M
2017	23.8M	24.2M	24.8M	25.4M
2016	21.4M	22.2M	23.1M	23.1M
2015	19.6M	19.8M	20.3M	21.1M
2014	19.7M	19.7M	19.9M	20.1M
2013	18.4M	18.8M	19.1M	19.0M
2012	17.6M	17.4M	17.6M	18.0M
2011	17.8M	17.8M	17.9M	17.9M
2010	0	0	0	17.8M

Get all data in R, Python etc through our Historical Stock Data APIs

About CRYO-CELL International, Inc.

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

CEO	Mr. David I. Portnoy
WEBSITE	cryo-cell.com
SECTOR	Healthcare
INDUSTRY	Medical Care Facilities
EMPLOYEES	80

CRYO-CELL International, Inc. Frequently Asked Questions

What is the ticker symbol for CRYO-CELL International, Inc.? What does CCEL stand for in stocks?

CCEL is the stock ticker symbol of CRYO-CELL International, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of CRYO-CELL International, Inc. (CCEL)?

As of Wed Nov 20 2024, market cap of CRYO-CELL International, Inc. is 62.72 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CCEL stock?

You can check CCEL's fair value in chart for subscribers.

Is CRYO-CELL International, Inc. a good stock to buy?

The fair value guage provides a quick view whether CCEL is over valued or under valued. Whether CRYO-CELL International, Inc. is cheap or expensive depends on the assumptions which impact CRYO-CELL International, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CCEL.

What is CRYO-CELL International, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Nov 20 2024, CCEL's PE ratio (Price to Earnings) is -7.03 and Price to Sales (PS) ratio is 1.97. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CCEL PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on CRYO-CELL International, Inc.'s stock?

In the past 10 years, CRYO-CELL International, Inc. has provided 0.104 (multiply by 100 for percentage) rate of return.